1. The clinical utility of PGD with HLA matching: A collaborative multi-centre ESHRE study
- Author
-
Kakourou, G. Kahraman, S. Ekmekci, G.C. Tac, H.A. Kourlaba, G. Kourkouni, E. Sanz, A.C. Martin, J. Malmgren, H. Giménez, C. Gold, V. Carvalho, F. Billi, C. Chow, J.F.C. Vendrell, X. Kokkali, G. Liss, J. Steffann, J. Traeger-Synodinos, J. and Kakourou, G. Kahraman, S. Ekmekci, G.C. Tac, H.A. Kourlaba, G. Kourkouni, E. Sanz, A.C. Martin, J. Malmgren, H. Giménez, C. Gold, V. Carvalho, F. Billi, C. Chow, J.F.C. Vendrell, X. Kokkali, G. Liss, J. Steffann, J. Traeger-Synodinos, J.
- Abstract
STUDY QUESTION Has PGD-HLA been successful relative to diagnostic and clinical efficacy? SUMMARY ANSWER The diagnostic efficacy of PGD-HLA protocols was found lower in this study in comparison to published PGD-HLA protocols and to that reported for general PGD by ESHRE (78.5 vs 94.1% and vs 92.6%, respectively), while the clinical efficacy has proven very difficult to assess due to inadequate follow-up of both the ART/PGD and HSCT procedure outcomes. WHAT IS KNOWN ALREADY The first clinical cases for PGD-HLA were reported in 2001. It is now a well-established procedure, with an increasing number of cycles performed every year. However, PGD-HLA is still offered by relatively few PGD centres, the currently available data is fragmented and most reports on PGD-HLA applications are limited in number and scope. Published systematic details on methodology, diagnostic results, overall ART success and haematopoietic stem cell transplantation (HSCT) outcomes are limited, precluding an evaluation of the true clinical utility of PGD-HLA cycles. STUDY DESIGN, SIZE, DURATION This retrospective multi-centre cohort study aimed to investigate the diagnostic and clinical efficacy of the PGD-HLA procedure and the aspects of PGD-HLA cycles influencing positive outcomes: birth of genetically suitable donor-baby (or babies) and HSCT. In April 2014, 32 PGD centres (Consortium members and non-members) with published/known PGD-HLA activity were invited to participate. Between February and September 2015, 14 centres submitted their data, through a custom-designed secure database, with unique login access for each centre. Data parameters covered all aspects of PGD-HLA cycles (ART, embryology and genetic diagnosis), donor-babies born and HSCT. PARTICIPANTS/MATERIALS, SETTING, METHODS From 716 cycles submitted by 14 centres (performed between August 2001 and September 2015), the quality evaluation excluded 12 cycles, leaving 704, from 364 couples. The online database, based on REDCap, a free, s
- Published
- 2018